Mumbai, India , is rapidly emerging as a key hub for the production of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established substantial manufacturing facilities focusing on this critical antiviral medicine . Identifying the absolute top manufacturers can be difficult due to f